SCHEDULE 13D

Beneficial Ownership Report

Chemomab Therapeutics Ltd. Filed 2026-11-10 Acc 0001493152-26-051041

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-11-10 SCHEDULE 13D Beneficial Ownership Report
2026-11-10 DEFA14A Proxy Materials
2026-11-03 6-K Report of Foreign Issuer
2026-07-16 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

External

SEC EDGAR (opens in new tab)